Postmenopausal hormone replacement therapy and insulin metabolism: Effects of route of administration and implications for heart disease and diabetes risk

British Journal of Clinical Practice

Volumn , Issue SUPPL. 86, 1996, Pages 1-5

  Godsland, I F ^a   Stevenson, J C ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; INSULIN; PROGESTERONE;

CORONARY ARTERY DISEASE; ESTROGEN THERAPY; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; LIVER; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; REVIEW;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; CORONARY DISEASE; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INSULIN; LIVER; MIDDLE AGED; POSTMENOPAUSE; PROGESTERONE;

EID: 0030229150     PISSN: 00070947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Jarrett R, McCartney P, Keen H. The Bedford Survey, ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk for coronary heart disease in borderline diabetics. Diabetologia 1982, 22: 79-84.
2. Fuller J, Shipley M, Rose G et al. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study. BMJ 1983; 287: 867-870.
3. Donahue R, Abbott R, Reed D, Katsuhiko Y. Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Diabetes 1987; 36: 689-692.
4. Welborn T, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979; 2:154-160.
5. Pyerälä K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 91/2 year follow-up of the Helsinki Policeman Study Population. Acta MedScand1985; 701 (Suppl): 38-52.
6. Fontbonne A, Charles MA, Thibult N et al. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year followup. Diabetologia 1991; 34: 356361.
7. Stout R. Insulin and atheroma: 20-year perspective. Diabetes Care 1990; 13: 631-654.
8. Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med1989; 149: 1514-1520.
9. Modan M, Halkin H, Almog S et al. Hyperinsulinaemia: a link between hypertension, obesity and glucose intolerance. J Clin /nvesf 1985; 75: 809-817.
10. Reaven G. Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1605.
11. Reaven G. Role of insulin resistance in human disease (Syndrome X): an expanded definition. Ann Rev Med 1993; 44: 121-131.
12. Baron AD. Cardiovascular actions of insulin in humans. Implications for insulin sensitivity and vascular tone. Ballieres Clin Endocrin Metab 1993; 7: 961987.
13. Nelson W, Overholser M. The effect of oestrogenic hormone on experimental pancreatic diabetes in the monkey. Endocrinology 1936; 20: 473-480.
14. Rodriguez R. Prevention of diabetes on forced fed rats under prolonged diethylstilbestrol administration. Proc Soc Exp Biol Med 1950; 73: 317-321.
15. Costrini N, Kalkhoff R. Relative effects of pregnancy, estradiol, and progesterone on plasma insulin and pancreatic islet insulin secretion. J Clin Invest 1971; 50: 992-999.
16. Matute M, Kalkhoff R. Sex steroid influence on hepatic gluconeogenesis and glycogen formation. Endocrinology\973; 92: 762-768.
17. Bailey C, Ahmed-Sorour H. Role of ovarian hormones in the long term control of glucose homeostasis. Diabetologia 1980; 19: 475-481.
18. Faure A, Sutter-Dub M-T. Insulin secretion from isolated pancreatic islets in the female rat. Short and long term estradiol influence. J Physiol (Paris) 1979; 75: 289-295.
19. Howell S, Tyhurst M, Green I. Direct effects of progesterone on rat islets of Langerhans in vivo and in tissue culture. Diabetologia 1977; 13: 579-583.
20. Green I, ElSeifi S, Perrin D, Howell S. Cell replication in the islets of Langerhans of adult rats: effects of pregnancy, ovariectomy and treatment with steroid hormones. J Endocrinol 1981 ; 88: 219-224.
21. Faure A, Haourari M, Sutter B-C-J. Insulin secretion and biosynthesis after oestradiol treatment. Horm Metab Res 1985; 17: 378.
22. McKerns K, Coulomb B, Kaleita E, DeRenzo E. Some effects of in vivo administered oestrogens on glucose metabolism and adrenal cortical secretion in vitro. Endocrinology 1958; 63: 709-722.
23. Gilmour K, McKerns K. Insulin and estrogen regulation of lipid synthesis in adipose tissue. Biochim Biophys Acta 1966; 116: 220-228.
24. Rushakoff R, Kalkhoff R. Effects of pregnancy and sex steroid administration on skeletel and muscle metabolism in the rat. Diabetes 1981; 30: 545-550.
25. Sutter B-C-J, Sutter-Dub M, Lerclerq R, Jacquot R. Inhibition of insulin action by progesterone in the rat (abstract). Diabetologia 1973; 9: 92.
26. Sutter-Dub M, Dazey B, Hamdan E, Vergnaud M. Progesterone and insulin-resistance: studies of progesterone action on glucose transport, lipogenesis and lipolysis in isolated fat cells of the female rat. J Endocrinol 1981; 88: 455-462.
27. Larsson-Cohn U, Wallentin L. Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. Acta Endocrinol 1977; 86: 583-596.
28. Spellacy W, Buhi W, Birk S. The effects of two years of mestranol treatment on carbohydrate metabolism. Metabolism 1982; 31: 1006-1008.
29. Ajabor LN, Tsai CC, Vela P, Yen SSC. Effect of exogenous estrogen on carbohydrate metabolism in postmenopausal women. Am J Obstet Gynecol 1972; 113:383-387.
30. Spellacy W, Buhi W, Birk S. Effect of estrogen treatment for one year on carbohydrate and lipid metabolism. Am J Obstet Gynecol 1978; 131: 87-90.
31. Silfverstolpe G, Gustafson A, Samsioe F, Svanborg A. Lipid metabolic studies in oophorectomised women: effects induced by two different estrogens on serum lipids and lipoproteins. Gynecol Obstet Invest 1980; 11: 161-169.
32. Crook D, Montgomery J, Godsland I et al. Lipid and carbohydrate metabolism in premenopausal women given subdermal estradiol pellets. Horm Metab Res 1991; 23: 174-177.
33. Kalkhoff R, Jacobson M, Lemper D. Progesterone, pregnancy and the augmented plasma insulin response. J Clin Endochnol 1970; 31: 24-28.
34. Adams PW, Wynn V. The effects of progestogen megestrol acetate on carbohydrate and lipid metabolism. J Obstet Gynecol Br Commonwealth 1972; 79: 744-752.
35. Spellacy W, McLeod A, Buhi W et al. Medroxyprogesterone acetate and carbohydrate metabolism: measurement of glucose, insulin and growth hormone during six months' time. Fertil Steril 1970; 21:457-463.
36. Spellacy W, Buhi W, Birk S. The effects of norgestrel on carbohydrate and lipid metabolism over one year. Am J Obstet Gynecol 1976; 125: 984-986.
37. Godsland I, Crook D, Simpson R et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 1990; 323: 1375-1381.
38. Walton C, Godsland I, Proudler A et al. The effects of the menopause on insulin sensitivity, secretion and elimination in nonobese, healthy women. Eur J Clin Invest 1993; 23: 466-473.
39. Proudler A, Felton C, Stevenson J. Ageing and the response of plasma insulin, glucose and C-peptide concentrations to intravenous glucose in postmenopausal women. Clin Sei 1992; 83: 489-494.
40. Godsland I, Walton C, Stevenson J. Impact of menopause on metabolism. In: Diamond MP, Naftolin F (eds) Metabolism in the Female Life Cycle. Rome: Ares Serono Symposia, 1993: 171-189.
41. Wynn Institute. Unpublished data.
42. Cagnacci A, Soldani R, Carriero P et al. Effects of low doses of transdermal 17-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 1992; 74: 1396-1400.
43. Godsland I, Gangar K, Walton C et al. Insulin resistance, secretion and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 1993; 42: 846-853.